Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ||||||||||
| Cost of revenue | -47.04%7.05M | 1,110.14%13.31M | 1.1M | |||||||
| Gross profit | 47.04%-7.05M | -1,110.14%-13.31M | -1.1M | |||||||
| Operating expense | -37.91%27.5M | -4.90%44.29M | 175.74%46.57M | 105.19%16.89M | 47.32%8.23M | -2.57%5.59M | -44.15%5.73M | -24.61%10.27M | 5.34%13.62M | 161.92%12.93M |
| Selling and administrative expenses | -50.39%9.96M | 78.45%20.08M | -20.66%11.25M | 146.95%14.18M | 79.91%5.74M | 3.14%3.19M | -37.93%3.09M | 14.61%4.99M | 61.53%4.35M | 56.49%2.69M |
| -Selling and marketing expense | 25.23%196.04K | -68.21%156.55K | --492.51K | ---- | ---- | ---- | ---- | ---- | ---- | --966.75K |
| -General and administrative expense | -50.99%9.76M | 85.16%19.92M | -24.13%10.76M | 146.95%14.18M | 79.91%5.74M | 3.14%3.19M | -37.93%3.09M | 14.61%4.99M | 151.98%4.35M | 0.32%1.73M |
| Depreciation amortization depletion | -68.99%4.38M | 1,828.52%14.11M | 242.91%731.77K | 18.81%213.4K | 48.56%179.62K | 0.65%120.9K | 91.93%120.12K | 84.69%62.59K | -68.37%33.89K | 5.37%107.13K |
| -Depreciation and amortization | -68.99%4.38M | 1,828.52%14.11M | 242.91%731.77K | 18.81%213.4K | 48.56%179.62K | 0.65%120.9K | 91.93%120.12K | 84.69%62.59K | -68.37%33.89K | 5.37%107.13K |
| Provision for doubtful accounts | --3.59M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | -5.19%9.57M | -70.81%10.1M | 1,287.65%34.58M | 7.99%2.49M | 1.49%2.31M | -9.73%2.27M | -51.72%2.52M | -43.49%5.22M | -8.82%9.23M | 225.32%10.13M |
| Operating profit | 40.02%-34.54M | -20.82%-57.59M | -182.25%-47.67M | -105.19%-16.89M | -47.32%-8.23M | 2.57%-5.59M | 44.15%-5.73M | 24.61%-10.27M | -5.34%-13.62M | -161.92%-12.93M |
| Net non-operating interest income (expenses) | 33.20%-10.21M | -51.55%-15.28M | -5,883.62%-10.08M | 33.75%174.36K | 23.28%130.36K | 309.89%105.75K | 6.87%25.8K | -11.72%24.14K | -53.92%27.35K | 60.55%59.35K |
| Non-operating interest income | -33.09%155.88K | 814.64%232.96K | -85.39%25.47K | 33.75%174.36K | 23.28%130.36K | 309.89%105.75K | 6.87%25.8K | -11.72%24.14K | -53.92%27.35K | 59.88%59.35K |
| Non-operating interest expense | -33.37%10.31M | 53.00%15.47M | --10.11M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total other finance cost | 22.11%57.18K | --46.83K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 33,975.03%53.77M | 104.00%157.81K | -986.25%-3.95M | -38.29%445.23K | 1,155.82%721.52K | -123.53%-68.34K | -40.21%290.37K | -68.94%485.65K | 514.65%1.56M | -35.21%-377.05K |
| Special income (charges) | 640.25%36.71K | -98.74%4.96K | 62.77%395.12K | --242.76K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | 640.25%36.71K | -98.74%4.96K | 62.77%395.12K | --242.76K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 35,056.50%53.74M | 103.52%152.85K | -2,243.98%-4.34M | -71.94%202.47K | 209.92%721.52K | -32.09%232.81K | -29.41%342.82K | -68.94%485.65K | 514.65%1.56M | -35.02%-377.05K |
| Income before tax | 112.41%9.02M | -17.86%-72.72M | -279.24%-61.7M | -120.48%-16.27M | -32.96%-7.38M | -2.43%-5.55M | 44.47%-5.42M | 18.88%-9.76M | 9.19%-12.03M | -155.82%-13.24M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 112.41%9.02M | -17.86%-72.72M | -279.24%-61.7M | -120.48%-16.27M | -32.96%-7.38M | -2.43%-5.55M | 44.47%-5.42M | 18.88%-9.76M | 9.19%-12.03M | -155.82%-13.24M |
| Net income continuous operations | 112.41%9.02M | -17.86%-72.72M | -279.24%-61.7M | -120.48%-16.27M | -32.96%-7.38M | -2.43%-5.55M | 44.47%-5.42M | 18.88%-9.76M | 9.19%-12.03M | -155.82%-13.24M |
| Noncontrolling interests | 59.13%-6.39M | -15.64M | -1,146.18%-4.92M | -395.09K | ||||||
| Net income attributable to the company | 127.01%15.42M | 7.49%-57.07M | -443.83%-61.7M | -62.46%-11.35M | -25.84%-6.98M | -2.43%-5.55M | 44.47%-5.42M | 18.88%-9.76M | 9.19%-12.03M | -155.82%-13.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 127.01%15.42M | 7.49%-57.07M | -443.83%-61.7M | -62.46%-11.35M | -25.84%-6.98M | -2.43%-5.55M | 44.47%-5.42M | 18.88%-9.76M | 9.19%-12.03M | -155.82%-13.24M |
| Diluted earnings per share | 125.20%0.0129 | 19.75%-0.0512 | -379.70%-0.0638 | -26.67%-0.0133 | -14.13%-0.0105 | 5.15%-0.0092 | 53.59%-0.0097 | 38.89%-0.0209 | 18.96%-0.0342 | -113.13%-0.0422 |
| Basic earnings per share | 125.20%0.0129 | 19.75%-0.0512 | -379.70%-0.0638 | -26.67%-0.0133 | -14.13%-0.0105 | 5.15%-0.0092 | 53.59%-0.0097 | 38.89%-0.0209 | 18.96%-0.0342 | -113.13%-0.0422 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |